Facilitating Drug Development with In Situ FT-IR and Data-Rich Experimentation
July 29, 2020
Learn how Merck applies in situ FTIR in data-rich experimentation. This webcast highlights past and ongoing efforts centering on enzyme discovery and reaction engineering, underpinned by data-rich experimentation methods including high-throughput experimentation and analysis, automation, and in situ reaction analysis using novel analytical tools. Furthermore, development of a robust process optimized for a commercially relevant synthetic chemistry reactor (vs. for example a more optimal bioreactor or fermenter) will be reviewed including demonstration across scales.
Live: Tues, Sept. 1, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after airing until Sept. 1, 2021